Thomas Schenk

2.5k total citations
59 papers, 1.5k citations indexed

About

Thomas Schenk is a scholar working on Hematology, Genetics and Neurology. According to data from OpenAlex, Thomas Schenk has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 14 papers in Genetics and 10 papers in Neurology. Recurrent topics in Thomas Schenk's work include Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Eosinophilic Disorders and Syndromes (5 papers). Thomas Schenk is often cited by papers focused on Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Eosinophilic Disorders and Syndromes (5 papers). Thomas Schenk collaborates with scholars based in Germany, United Kingdom and Austria. Thomas Schenk's co-authors include Adam Noble, Susi Kriemler, Manfred Ballmann, Sibylle Junge, Alexandra Hebestreit, Helge Hebestreit, Andreas Hochhaus, Benjamin Hanfstein, Rüdiger Hehlmann and Kathrin S. Utz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Thomas Schenk

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Schenk Germany 23 354 350 238 206 172 59 1.5k
Laura Conti Italy 24 231 0.7× 242 0.7× 76 0.3× 126 0.6× 33 0.2× 99 1.7k
Valentina Bianchi Italy 23 380 1.1× 82 0.2× 228 1.0× 98 0.5× 198 1.2× 67 2.2k
George B. Selby United States 19 482 1.4× 64 0.2× 327 1.4× 160 0.8× 65 0.4× 99 1.8k
Natasha Mirza United States 26 81 0.2× 744 2.1× 156 0.7× 78 0.4× 55 0.3× 102 2.1k
Michael Bynevelt Australia 25 152 0.4× 221 0.6× 354 1.5× 196 1.0× 107 0.6× 58 1.5k
Brian Hon‐Yin Chung Hong Kong 26 124 0.4× 215 0.6× 136 0.6× 193 0.9× 427 2.5× 152 2.7k
Jennifer Armstrong United States 24 347 1.0× 262 0.7× 269 1.1× 54 0.3× 89 0.5× 77 1.5k
J. Thomsen Denmark 20 284 0.8× 274 0.8× 72 0.3× 89 0.4× 41 0.2× 48 1.3k
Tiina Talvik Estonia 23 274 0.8× 227 0.6× 199 0.8× 98 0.5× 94 0.5× 80 1.7k
Robert Elashoff United States 22 369 1.0× 298 0.9× 98 0.4× 86 0.4× 50 0.3× 37 2.2k

Countries citing papers authored by Thomas Schenk

Since Specialization
Citations

This map shows the geographic impact of Thomas Schenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schenk more than expected).

Fields of papers citing papers by Thomas Schenk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schenk. The network helps show where Thomas Schenk may publish in the future.

Co-authorship network of co-authors of Thomas Schenk

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schenk. A scholar is included among the top collaborators of Thomas Schenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schenk. Thomas Schenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schenk, Thomas, et al.. (2025). IL-2 mediates human bystander CD8+ T-cell responses to innate immune signals. The Journal of Immunology. 214(12). 3399–3412.
2.
Ernst, Philipp, Christine M. Lohse, Michael Lauseker, et al.. (2025). Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective. Leukemia. 40(1). 29–36.
3.
Nyvlt, Peter, Friederike S. Schuster, Jana Ihlow, et al.. (2024). Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients. European Journal Of Haematology. 112(6). 917–926. 2 indexed citations
4.
Flanagin, Virginia L., et al.. (2022). Impaired Emotion Processing and Panic Disorder After Left Anterior Temporal Lobectomy: A Case Report of Successful Psychotherapeutic Intervention. Cognitive Therapy and Research. 46(4). 838–851. 1 indexed citations
5.
Schenk, Thomas, Jacqueline Maier, Georg‐Nikolaus Franke, et al.. (2019). Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry). Journal of Cancer Research and Clinical Oncology. 145(6). 1645–1650. 8 indexed citations
6.
Knossalla, Frauke, Zacharias Kohl, Jürgen Winkler, et al.. (2018). High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson’s disease. Journal of Clinical Neuroscience. 50. 199–202. 14 indexed citations
7.
Marxreiter, Franz, Zacharias Kohl, Johannes C. M. Schlachetzki, et al.. (2015). From sweet to sweat: Hedonic olfactory range is impaired in Parkinson's disease. Parkinsonism & Related Disorders. 22. 9–14. 22 indexed citations
8.
Hebestreit, Helge, Sibylle Junge, Manfred Ballmann, et al.. (2014). Quality of life is associated with physical activity and fitness in cystic fibrosis. BMC Pulmonary Medicine. 14(1). 26–26. 106 indexed citations
9.
Noble, Adam & Thomas Schenk. (2014). Psychological distress after subarachnoid hemorrhage: Patient support groups can help us better detect it. Journal of the Neurological Sciences. 343(1-2). 125–131. 12 indexed citations
10.
Härtel, Nicolai, Thomas Klag, Benjamin Hanfstein, et al.. (2011). Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity. Journal of Cancer Research and Clinical Oncology. 138(2). 203–212. 5 indexed citations
11.
12.
Ellison, Amanda, Amy R. Lane, & Thomas Schenk. (2007). The Interaction of Brain Regions during Visual Search Processing as Revealed by Transcranial Magnetic Stimulation. Cerebral Cortex. 17(11). 2579–2584. 40 indexed citations
13.
Hebestreit, Helge, Stefan G. Rüdiger, Thomas Schenk, et al.. (2006). Physical activity is independently related to aerobic capacity in cystic fibrosis. European Respiratory Journal. 28(4). 734–739. 100 indexed citations
14.
Schenk, Thomas, et al.. (2003). Effects of deep brain stimulation on prehensile movements in PD patients are less pronounced when external timing cues are provided. Neuropsychologia. 41(7). 783–794. 34 indexed citations
15.
16.
Schenk, Thomas & Norbert Mai. (1999). Time constraints improve reaching movements in an ataxic patient. Experimental Brain Research. 128(1-2). 214–218. 5 indexed citations
17.
Schenk, Thomas. (1997). Visual motion perception after brain damage: I. Deficits in global motion perception. Neuropsychologia. 35(9). 1289–1297. 78 indexed citations
18.
Fiegl, Michael, Thomas Schenk, R. Jakesz, et al.. (1995). Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. British Journal of Cancer. 72(1). 51–55. 42 indexed citations
19.
Scheithauer, Werner, Gabriela Kornek, K. Haider, et al.. (1993). Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C. Breast Cancer Research and Treatment. 26(1). 49–53. 20 indexed citations
20.
Scheithauer, Werner, Thomas Schenk, & Martin Czejka. (1993). Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil. British Journal of Cancer. 68(1). 8–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Conti Breakdown of academic impact, for papers by Valentina Bianchi Breakdown of academic impact, for papers by George B. Selby Breakdown of academic impact, for papers by Natasha Mirza Breakdown of academic impact, for papers by Michael Bynevelt Breakdown of academic impact, for papers by Brian Hon‐Yin Chung Breakdown of academic impact, for papers by Jennifer Armstrong Breakdown of academic impact, for papers by J. Thomsen Breakdown of academic impact, for papers by Tiina Talvik Breakdown of academic impact, for papers by Robert Elashoff
Rankless by CCL
2026